secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTUATE THERAPEUTICS, INC. (ACTU)
CIK:        0001652935
Form:       8-K
Filed at:   2026-07-17T20:30:34+00:00
Accession:  0001683168-26-005616
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Actuate Therapeutics receives Nasdaq delisting notice for MVLS below $50M
-------------------------------------------------------------------------

- Received Nasdaq notice on July 15, 2026 that Market Value of Listed Securities fell below $50M minimum.
- Has 180 calendar days, until January 11, 2027, to regain compliance by closing at $50M+ for 10 consecutive days.
- If not compliant by deadline, Nasdaq will issue delisting notice; company may appeal or apply to transfer to Nasdaq Capital Market.
- Common stock continues trading under symbol ACTU with no immediate effect on listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652935/000168316826005616/0001683168-26-005616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652935/000168316826005616/actuate_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-005616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer